MED20 and chronic myelogenous leukemia, BCR-ABL1 positive: CD36 (scavenger receptor-B2 (SR-B2)) is a marker of immature CML cells that its upregulated expression on CD34+CD38low CML cells in chronic phase leads to less sensitivity to IM treatment [39].